Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ashley L. Ward, MD
MacroGenics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Institut Paoli-Calmettes
Marseille, France
- Centre Hospitalier Universitaire de Nantes
Nantes, France
- Institut Universitaire Du Cancer de Toulouse-Oncopole
Toulouse, France
- Chru de Tours - Hôpital Bretonneau
Tours, France
- Charité - Universitätsmedizin Berlin
Berlin, Germany
- Universitätsklinikum Carl Gustav Carus An Der Technischen Universität Dresden
Dresden, Germany
- Universitätsklinik Hamburg-Eppendorf
Hamburg, Germany
- Universitätsklinikum Leipzig
Leipzig, Germany
- Universitätsmedizin Der Johannes Gutenberg-Universität Mainz
Mainz, Germany
- Iii. Med. Klinik-Klinikum Rechts Der Isar-Technische Universität München
Munich, Germany
- Medizinische Klinik Und Ii, Universitätsklinikum Würzburg
Würzbur, Germany
- Rambam Health Care Campus
Haifa, Israel
- Shaare Zedek Medical Center
Jerusalem, Israel
- Policlinico Sant'Orsola Malpighi
Bologna, Italy
- Istituto Scientifico Romagnolo Per Lo Studio E la Cura Dei Tumori (irst)
Meldola, Italy
- University Vita-Salute San Raffaele
Milan, Italy
- Unità Operativa Di Ematologia Ospedale Santa Maria Delle Croci
Ravenna, Italy
- University Medical Center Groningen
Groningen, Netherlands
- Erasmus University Medical Center
Rotterdam, Netherlands
- Universitat Autonomaa de Barcelona (uab) - Hospital de la Santa Creu I de Sant Pau
Barcelona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- King'S Health Partners
London, United Kingdom
- the Christie Nhs Foundation Trust
Manchester, United Kingdom
- City of Hope National Medical Center
Duarte, California, United States
- Ucsd Moores Cancer Center
La Jolla, California, United States
- Ucsf - Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Georgetown University - Lombardi Cancer Center
Washington D.C., District of Columbia, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Loyola University Chicago - Cardinal Bernadin Cancer Center
Maywood, Illinois, United States
- University of Maryland
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Stony Brook Medicine
Stony Brook, New York, United States
- University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jun 2014
- Primary completion
- 5 Jul 2022
- Completion
- 5 Jul 2022
- Last update posted
- 30 Jan 2024
- Registered enrollment
- 244
- Registry id
- NCT02152956
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.